View Older Stories View More Recent Stories
-
A123 Systems (AONE) Sees IPO Price of $8-$9.50
-
Lazard Capital Initiates Coverage on Oracle (ORCL) with a Buy
-
After-Hours Movers 9/8: CASY, SB, TXT Higher; UWBK, RPT, VGZ, RTI, PBY, AVAV, ENTG, EAC Lower
-
Lazard Ltd (LAZ) To Sell 5.2M Shares For Shareholders
-
Notable Analyst Rating Changes 9/1: MOT, RIMM, VALE, BHI, BHP, COH, LMT Upgraded; AIG, NOK, QCOM, ALU, AXL, VZ Downgraded
-
Lazard Capital Initiates Coverage on Polycom (PLCM) with a Hold
-
Lazard Capital Downgrades Marvel Entertainment (MVL) to Hold
-
Goldman Sachs Upgrades Mid-Cap Brokers Group; Moves Greenhill (GHL) to Neutral, Reiterates Buys on Piper Jaffray (PJC), Lazard (LAZ)
-
Fox Pitt Downgrades Lazard Ltd (LAZ) to In-Line
-
Lazard Capital Upgrades Threshold Pharmaceuticals (THLD) to Buy
-
StreetInsider.com's Best of the Web 8/18
-
Lazard (LAZ) Names Tom Tuft as Chairman, Global Capital Markets
-
Lazard Capital Markets Upgrades Shire Limited (SHPGY) to Buy
-
Lazard Starts NetSuite (N) at Hold
-
Onyx Pharmaceuticals (ONXX) Sells 4M Shares at $30.50, $200M Conv Noves
-
CDC Software (CDCS) IPO Trades Lower
-
Lazard Capital Downgrades Poniard Pharmaceuticals (PARD) to Hold
-
Unusual 11 Mid-Day Movers 7/31: ANDS, IBNK, INO, DSCM Higher; SYNA, ARIA, SFI, PIR Lower
-
Notable Analyst Rating Changes 7/31: CNX, CL, MOT, OMX Upgraded; LVS, DIS, FSLR, K, SYNA, RATE, RTP, LM Downgraded
-
Lazard Capital Downgrades Synaptics (SYNA) to Hold
-
Lazard Capital Downgrades Thoratec (THOR) to Hold
-
Lazard Capital Downgrades Itron (ITRI) to Hold
-
David Moenning's Daily State of the Markets: 7/29
-
Lazard (LAZ) Reports Solid Q2 Results
-
Lazard (LAZ) Boosts Qtr. Dividend by 25% to $0.125, Yielding 1.64%
-
Lazard Starts TiVo (TIVO) at Buy
-
Coach (COH) calls active on low volatility into EPS and productivity outlook
-
Coach (COH) Tumbles as Lazard Downgrades to Hold
-
Analysts Weigh In On eBay (EBAY) Following Better-Than-Expected Q2, Good But More Work Ahead; Stock Up 10%
-
Analysts Still Jumping on Human Genome Sciences (HGSI) Bandwagon: 3 Upgrades Today
-
Lazard Starts EMC (EMC) at Buy
-
Citi & Lazard Capital Jump on Bandwagon - Upgrade Human Genome Sciences (HGSI)
-
Lazard Upgrades Trina (TSL), Canadian Solar (CSIQ) to Buy
-
CDC (CHINA) Software Files for IPO of ADS; Sees Offering Range of $11-$13
-
Notable Analyst Rating Changes 7/14: BK, UL, VMW, CNK, NILE Upgraded; MNKD, MAS, BKC, VOD Downgraded
-
Lazard Capital Upgrades Cinemark (CNK) to Buy
-
Lazard Capital Initiates Coverage on Sepracor (SEPR) with a Hold
-
Lazard Capital Upgrades Atheros Communications (ATHR) to Buy
-
Lazard Capital Downgrades ImmunoGen (IMGN) to Hold
-
Lazard Starts Boston Scientific (BSX) at Hold
-
Lazard Capital Downgrades Hansen Medical (HNSN) to Hold
-
Lazard Capital Initiates Coverage on Callaway Golf (ELY) with a Buy
-
Unusual 11 Mid-Day Movers 7/6: MRCY, PLX, OXGN, SNWL Higher; RGS, TSTR, SPPI, AXL Lower
-
Lazard Capital Starts Endologix (ELGX) at Buy
-
Lazard Capital Initiates Coverage on McKesson (MCK) with a Buy
-
Lazard Capital Initiates Coverage on AmerisourceBergen (ABC) with a Buy
-
Lazard Capital Initiates Coverage on Cardinal Health (CAH) with a Hold
-
Clean Energy Fuels (CLNE) Prices Follow-On Offering of 8.2M Shares At $8.30 A Share
-
Cell Genesys (CEGE) Reports Tender Offer Results, Continues to Pursue Strategic Alternatives
-
FuelCell Energy (FCEL) to Sell 6.7M Shares at $3.59

